Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Emergent Biosolutions
(NY:
EBS
)
8.800
-0.480 (-5.17%)
Streaming Delayed Price
Updated: 1:06 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Emergent Biosolutions
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
July 31, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
Why Emergent BioSolutions Stock Dived by 9% Today
June 27, 2023
Investors didn't greet news of the CEO's departure warmly.
Via
The Motley Fool
Is Emergent BioSolutions Stock a Buy Now?
June 09, 2023
The deluge of bad news seems to be over, and a recovery could be in the works.
Via
The Motley Fool
Down 75%, Can Emergent BioSolutions Turn Things Around?
June 07, 2023
Has the stock finally bottomed out?
Via
The Motley Fool
Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023
July 25, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Potential Delay In iPhone 15 Debut Could Impact Apple's Margins, Meta's Threads App Faces User Exodus, Microsoft CEO Satya Nadella's Earnings Exceed $1B: Today's Top Stories
July 21, 2023
New York Times
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 21, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Emergent BioSolutions
May 31, 2023
Via
Benzinga
Recap: Emergent BioSolutions Q1 Earnings
May 09, 2023
Via
Benzinga
Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
July 21, 2023
Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 21, 2023
It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Emergent BioSolutions' Two-Dose Anthrax Vaccine Secures FDA Nod; Shares Jump
July 21, 2023
The FDA approved Emergent BioSolutions Inc's (NYSE: EBS) anthrax vaccine for adults
Via
Benzinga
Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
July 20, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
July 05, 2023
Wednesday's session saw 43 companies set new 52-week lows.
Via
Benzinga
Emergent BioSolutions Announces CEO Transition
June 27, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Better Recovery-Story Buy: Emergent BioSolutions or Invitae?
June 26, 2023
Both of these stocks have plummeted more than 50% over the past year.
Via
The Motley Fool
Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data
June 20, 2023
Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in
Via
Benzinga
Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment
May 23, 2023
The FDA has approved Indivior PLC's (OTC: INVVY) Opvee (nalmefene) nasal spray for the emergency treatment of opioid overdose in adults and pediatric patients aged 12 years and older.
Via
Benzinga
Why Emergent BioSolutions Stock Inched Slightly Higher Today
May 15, 2023
Investors approved, if not enthusiastically, their company's latest asset sale.
Via
The Motley Fool
Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic
May 15, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT
May 11, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 12, 2023
Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...
Via
Benzinga
Emergent BioSolutions (EBS) Q1 2023 Earnings Call Transcript
May 10, 2023
EBS earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Emergent BioSolutions Reports Financial Results For First Quarter 2023
May 09, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
Emergent Plans $50 Price Point For Narcan OTC Version For Opioid Overdose Reversal
April 21, 2023
Emergent BioSolutions Inc (NYSE: EBS) looks to price its over-the-counter (OTC) version of its opioid overdose reversal Narcan at around $50 per carton of two 4 mg doses.
Via
Benzinga
Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023
April 19, 2023
From
Emergent BioSolutions
Via
GlobeNewswire
CPI Sent Market Surging - But Some Stocks Took A Hit: Spotlight On Top Gainers And Hard-Hit Decliners
April 12, 2023
The market is trading higher on Wednesday after the Labor Department reported the latest Consumer Price Index figure for the month of March. While most stocks are trading higher alongside the major...
Via
Benzinga
Tesla, Apple, Riot Platforms, AMC, Emergent Biosolutions: Why These 5 Stocks Are Drawing Investors' Attention Today
April 10, 2023
U.S.
Via
Benzinga
Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move
April 10, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.